SCHEMBL10686116

SCHEMBL10686116

Nc1ccc2ccc(-c3ccccc3Cl)nc2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.50
BACE1 P56817 2/20 0.50
HSP90AA1 P07900 2/20 0.47
HSP90AB1 P08238 1/20 0.47
L3MBTL1 Q9Y468 2/20 0.40
IDO1 P14902 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
MAPK14 Q16539 1/20 0.38
ATP4A P20648 2/20 0.38
ATP4B P51164 2/20 0.38
ALDH1A1 P00352 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14877433 0.79 BACE1 (0.50) BACE1L3MBTL1IDO1NPC1RAB9A
SCHEMBL1915309 0.78 ASIC3 (0.53) PTPN1BACE1HSP90AA1HSP90AB1L3MBTL1
SCHEMBL30251342 0.78 ASIC3 (0.53) PTPN1BACE1HSP90AA1HSP90AB1L3MBTL1
SCHEMBL10691713 0.76 PTPN1 (0.54) PTPN1HSP90AA1HSP90AB1L3MBTL1RAB9A
SCHEMBL1916434 0.74 HSP90AA1 (0.49) PTPN1BACE1HSP90AA1HSP90AB1L3MBTL1
SCHEMBL9375675 0.74 ASIC3 (0.59) BACE1HSP90AA1NPC1RAB9AMEN1
SCHEMBL1765925 0.72 BACE1 (0.48) BACE1KMT2AALDH1A1KDM4ENCF1
SCHEMBL10691587 0.71 BACE1 (0.50) BACE1NPC1RAB9AMEN1MAPT
SCHEMBL10689287 0.71 KMO (0.53) BACE1L3MBTL1NPC1RAB9AMAPT
SCHEMBL6412343 0.71 PIK3CD (0.40) BACE1IDO1NPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4720500-A N-1,8-naphthyridin-2-yl amides useful as immunostimulants RHONE-POULENC SANTE (FR) 1988-01-19 US disclosed